| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $55.2M | — | +89.5% |
| Cost of Revenue | $21.4M | — | +18.9% |
| Gross Profit | $33.8M | — | +203.7% |
| R&D Expense | $2.5M | — | +44.3% |
| SG&A Expense | $3.9M | — | +51.5% |
| Operating Income | $27.3M | — | +304.9% |
| Pre-tax Income | $28.4M | — | +310.2% |
| Income Tax | $7.2M | — | +335.2% |
| Net Income | $21.2M | — | +302.3% |
| EPS (Basic) | $0.25 | — | +316.7% |
| EPS (Diluted) | $0.25 | — | +316.7% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $140.9M | — | — |
| Current Assets | $162.6M | — | — |
| Total Assets | $182.3M | — | — |
| Current Liabilities | $93.9M | — | — |
| Total Liabilities | $103.8M | — | — |
| Stockholders' Equity | $78.4M | +38.7% | +2308.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Capital Expenditures | $2.4M | — | — |
| Financing Cash Flow | $0 | — | — |